A carregar...
Risks and benefits of combining denosumab and surgery in giant cell tumor of bone—a case series
BACKGROUND: The RANK ligand inhibitor denosumab is being investigated for treatment of giant cell tumor of bone, but the available data in the literature remains sparse and controversial. This study analyzes the results of combining denosumab with surgical treatment and highlights possible changes f...
Na minha lista:
| Publicado no: | World J Surg Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5095954/ https://ncbi.nlm.nih.gov/pubmed/27809843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-016-1034-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|